Find, compare & contact

Omigapil API Manufacturers

teaser-1024x654-1
Contact suppliers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Omigapil is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Omigapil or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Omigapil API 181296-84-4?

Description:
Here you will find a list of producers, manufacturers and distributors of Omigapil. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Omigapil 
Synonyms:
 
Cas Number:
181296-84-4 
DrugBank number:
DB12879 
Unique Ingredient Identifier:
5V14HD0N4Q

General Description:

Omigapil, identified by CAS number 181296-84-4, is a notable compound with significant therapeutic applications. Omigapil has been used in trials studying the treatment of Congenital Muscular Dystrophy.

Classification:

Omigapil belongs to the class of organic compounds known as dibenzoxepines. These are compounds containing a dibenzoxepine moiety, which consists of two benzene connected by an oxazepine ring, classified under the direct parent group Dibenzoxepines. This compound is a part of the Organic compounds, falling under the Organoheterocyclic compounds superclass, and categorized within the Benzoxepines class, specifically within the Dibenzoxepines subclass.

Categories:

Omigapil is categorized under the following therapeutic classes: Ethers, Ethers, Cyclic. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.